
Glaxosmithkline Pharmaceuticals Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-11-17 09:03:20Glaxosmithkline Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 16 Nov 2026, reflecting a nuanced shift in its technical outlook and valuation metrics despite strong financial performance and management efficiency. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this decision, providing investors with a comprehensive understanding of the stock’s current standing.
Read More
Glaxosmithkline Pharmaceuticals Ltd is Rated Buy
2026-11-15 10:10:29Glaxosmithkline Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 15 November 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.
Read MoreGlaxosmithkline Pharmaceuticals Gains 5.73%: 4 Key Technical Shifts Driving the Week
2026-11-14 15:02:45Key Events This Week 09 Nov: Intraday high with 5.65% surge to Rs.2,688.30 11 Nov: Shift to mildly bullish momentum with 6.77% gain closing at Rs.2,710.85 12 Nov: Technical momentum upgraded to bullish, closing at Rs.2,726.40 13 Nov: Mildly bullish trend amid mixed indicators, closing at Rs.2,655.30 Week Open Rs.2,524.85 ...
Read More
Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators
2026-11-13 08:03:59Glaxosmithkline Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-November 2026. Despite a recent day decline of 2.61%, the stock’s broader technical indicators reveal a complex interplay of bullish and bearish signals, reflecting a cautious market sentiment amid sectoral and macroeconomic factors.
Read More
Glaxosmithkline Pharmaceuticals Ltd Surges 5.65% to Day's High of Rs 2688.3 — Outperforms Sector by 3.92 Percentage Points
2026-11-09 10:21:46The Sensex declined 0.22% on 09 Nov 2026 while Glaxosmithkline Pharmaceuticals Ltd surged 5.65%, outperforming its sector by nearly 4 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly weaker market, signalling a noteworthy shift in short-term momentum.
Read MoreGlaxosmithkline Pharmaceuticals Gains 1.66%: Mixed Technical Signals Shape Weekly Performance
2026-11-07 15:05:53Key Events This Week 2 Nov: Stock opens strong at Rs.2,528.35 (+1.80%) amid positive market sentiment 3 Nov: Mojo Grade upgraded to Hold; stock rises to Rs.2,573.30 (+1.78%) 4 Nov: Technical momentum shifts to sideways; stock dips to Rs.2,532.60 (-1.58%) 5 Nov: Daily moving averages turn mildly bullish despite price decline to Rs.2,500.70 (-1.26%) 6 Nov: Stock rebounds to Rs.2,524.85 (+0.97%) closing the week <...
Read More
Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators
2026-11-05 08:04:27Glaxosmithkline Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance despite mixed signals from key indicators. The stock’s recent downgrade from a Sell to a Hold rating by MarketsMOJO reflects this evolving technical landscape, as investors weigh the implications of fluctuating momentum against broader market conditions.
Read MoreGlaxosmithkline Pharmaceuticals Gains 3.27%: 4 Key Factors Driving the Week
2026-10-31 16:00:05Key Events This Week 26 Oct: Stock opens strong at ₹2,448.15 with a 1.80% gain 27 Oct: Technical momentum shifts amid mixed signals; stock rises 1.66% 29 Oct: Technical momentum turns mildly bearish despite a 0.32% gain 30 Oct: MarketsMOJO upgrades rating to Hold; stock closes at ₹2,483.55 (-1.28%) Week Open Rs.2,404.80 ...
Read More
Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts to Mildly Bullish
2026-10-30 08:01:52Glaxosmithkline Pharmaceuticals Ltd has recently exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend. This change is underscored by a combination of mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment for the mid-cap pharmaceutical player.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
18-Nov-2026 | Source : BSEAs per attachment
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
17-Nov-2026 | Source : BSEPostal Ballot Notice for approval of Related Party Transactions
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
08-Nov-2026 | Source : BSEAs per attachment
Corporate Actions
No Upcoming Board Meetings
Glaxosmithkline Pharmaceuticals Ltd has declared 570% dividend, ex-date: 29 May 26
No Splits history available
Glaxosmithkline Pharmaceuticals Ltd has announced 1:1 bonus issue, ex-date: 11 Sep 18
No Rights history available